PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Bill on penalties for “medication intoxication” while driving passes first reading

On Tuesday, the State Duma passed in the first reading a government-sponsored bill introducing administrative liability for drivers who operate vehicles under the influence of certain medications.

Bill No. 379447-8 proposes amendments to Articles 12.8 and 12.27 (Part 3) of the Russian Code of Administrative Offenses (KoAP), expanding the scope of punishable intoxication. Under the draft, drivers would be held administratively liable not only for alcohol or drug intoxication, but also in cases where medical examinations detect the presence of substances (or groups of substances) from medications that impair attention and reaction, even if these substances are not classified as alcohol, narcotics, psychotropics, their analogues, or other new potentially hazardous psychoactive substances. Liability would apply if a combination of clinical signs of intoxication is observed due to such substances.

These amendments aim to make “medication intoxication” punishable under administrative law.

Currently, the absence of a rule in the KoAP allowing for penalties against drivers impaired by certain medications complicates efforts to ensure road safety, according to the explanatory note.

A list of relevant medications will be defined by a government decree. It may include anesthetics, anti-epileptic drugs, sleeping pills, sedatives, and others.

The procedure for medical examination to determine intoxication will be amended with a new section that establishes rules for detecting impairment caused by medications that reduce a driver’s ability to react.

Source: Interfax, May 16, 2025

Current news

  • July 7, 2025

    PharmEco to Launch Oncology Drug Production with ₽9.1 Billion Investment

    The PharmEco Group of Companies will build a pharmaceutical manufacturing facility for oncology treatments in…

  • July 7, 2025

    Russian Government Introduces New Procedure for Releasing Medicines into Civil Circulation

    The Russian government has approved updated regulations governing the release of medicines into civil circulation.…

  • July 7, 2025

    National Preference Benefits Will Now Apply to All Russian-Made Medicines, Not Just Those on the Vital Drugs List

    The Russian government has amended its decree on measures for granting national treatment in the…

  • July 7, 2025

    Medicine Sales in Russia Surpass 1 Trillion Rubles Since Beginning of the Year

    From January to April 2025, medicine sales in Russia reached 1.03 trillion rubles. Compared to…

  • July 7, 2025

    Pfizer CEO Proposes a “Pharmaceutical NATO” with Fixed Spending on Medicines

    Pfizer CEO Albert Bourla has called on European countries to increase their spending on medicines.…

LLC “BioJet”. all rights reserved

  • Legal information